PIB’S Bulletin on COVID-19

  • Over 172  cr vaccine doses have been administered so far under Nationwide Vaccination Drive
  • India’s Active caseload currently stands at 6,97,802
  • Active cases stand at 1.64%
  • Recovery Rate currently at 97.17%
  • 1,50,407 recoveries in the last 24 hours increases Total Recoveries to 4,13,31,158
  • 58,077 new cases recorded in the last 24 hours
  • Daily positivity rate (3.89%)
  • Weekly Positivity Rate (5.76%)
  • 74.78 cr Total Tests conducted so far; 14,91,678 tests conducted in the last 24 hours

       #Unite2FightCorona                                                                                    #IndiaFightsCorona










India’s Cumulative COVID-19 Vaccination Coverage exceeds 172 Cr

More than 48.18 lakh Vaccine Doses administered in the last 24 hours

Recovery Rate currently stands at 97.17%

58,077 New Cases reported in the last 24 hours

India’s Active Caseload currently stands at 6,97,802

Weekly Positivity Rate is presently at 5.76%
India’s cumulative COVID-19 vaccination coverage has exceeded 172 Cr today afternoon. This has been achieved through 1,91,96,734 sessions. The break-up of the cumulative figure as per the provisional report till 7 am today include:


Cumulative Vaccine Dose Coverage
HCWs 1st Dose 1,03,98,922
2nd Dose 99,21,243
Precaution Dose 38,09,239
FLWs 1st Dose 1,84,04,139
2nd Dose 1,73,56,693
Precaution Dose 51,50,607
Age Group 15-18 years 1st Dose 5,13,17,677
2nd Dose 1,20,51,032
Age Group 18-44 years 1st Dose 54,70,41,238
2nd Dose 42,29,50,695
Age Group 45-59 years 1st Dose 20,14,14,698
2nd Dose 17,55,24,406
Over 60 years 1st Dose 12,57,25,893
2nd Dose 10,93,53,037
Precaution Dose 75,31,913
Precaution Dose 1,64,91,759
Total 1,71,79,51,432



1,50,407 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,13,31,158.

Consequently, India’s recovery rate stands at 97.17%




58,077 new cases were reported in the last 24 hours.



India’s Active Caseload is presently at 6,97,802. Active cases constitute 1.64% of the country’s total Positive Cases


The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 14,91,678 tests being conducted. India has so far conducted over 74.78 Cr (74,78,70,047) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate in the country currently stands at 5.76% and the Daily Positivity rate is reported to be 3.89%.






Update on COVID-19 Vaccine Availability in States/UTs

More than 169.73 Crore vaccine doses provided to States/UTs

More than 12.05 Crore balance and unutilized vaccine doses still available with States/UTs
The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The nationwide COVID 19 vaccination started on 16th January 2021. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain.

As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.




(As on 11th February, 2022)

SUPPLIED 1,69,73,06,050
BALANCE AVAILABLE   12,05,64,491


More than 169.73 crore (1,69,73,06,050) vaccine doses have been provided to States/UTs so far through Govt. of India (free of cost channel) and through direct state procurement category.

More than 12.05 Cr (12,05,64,491) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.



Tweet links

Be the first to comment

Leave a Reply

Your email address will not be published.